Neuland Laboratories Ltd.
| BSE: 524558 | Sector: Health care |
| NSE: NEULANDLAB | ISIN Code: INE794A01010 |
| BSE 00:00 | 20 Mar | 1628.45 |
-22.70 (-1.37%) |
OPEN
1667.00 |
HIGH
1667.00 |
LOW
1617.00 |
| NSE 00:00 | 20 Mar | 1625.50 |
-30.55 (-1.84%) |
OPEN
1656.00 |
HIGH
1665.50 |
LOW
1614.20 |
| OPEN | 1667.00 |
| PREVIOUS CLOSE | 1651.15 |
| VOLUME | 927 |
| 52-Week high | 2004.05 |
| 52-Week low | 965.85 |
| P/E | 20.75 |
| Mkt Cap.(Rs cr) | 2,089 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Neuland Laboratories Ltd. (NEULANDLAB) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 961.25 | 3.50 | 0.37 | 15585.98 |
| Dr Reddy's Labs | 4441.80 | 6.80 | 0.15 | 14405.20 |
| Cipla | 867.25 | -7.05 | -0.81 | 13091.79 |
| Lupin | 646.20 | -11.00 | -1.67 | 11771.67 |
| Aurobindo Pharma | 474.25 | -1.55 | -0.33 | 11287.14 |
| Divi's Lab. | 2798.95 | 8.85 | 0.32 | 8879.82 |
| Alkem Lab | 3108.65 | -6.10 | -0.20 | 8829.81 |
| Glenmark Pharma. | 445.00 | 4.25 | 0.96 | 8141.58 |
| Zydus Lifesci. | 475.85 | -1.00 | -0.21 | 7981.90 |
| Torrent Pharma. | 1522.10 | -8.40 | -0.55 | 6742.32 |
| Apollo Hospitals | 4305.45 | -42.90 | -0.99 | 6098.30 |
| Ipca Labs. | 780.85 | -1.35 | -0.17 | 5399.36 |
| Alembic Pharma | 479.25 | 1.30 | 0.27 | 5035.41 |
| Abbott India | 21304.00 | 394.80 | 1.89 | 4919.27 |
| Laurus Labs | 302.40 | -0.65 | -0.21 | 4707.04 |
| Gland Pharma | 1163.80 | -24.60 | -2.07 | 4400.71 |
| Granules India | 281.85 | -3.55 | -1.24 | 3238.44 |
| Glaxosmi. Pharma | 1281.75 | -6.40 | -0.50 | 3217.51 |
| Ajanta Pharma | 1183.05 | 14.75 | 1.26 | 3140.64 |
| Piramal Pharma | 67.23 | 0.14 | 0.21 | 3094.95 |
Quick Links for Neuland Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
